250 Participants Needed

Survivorship Care Plan for Cancer

(SPHERE Trial)

Recruiting at 1 trial location
DA
Overseen ByDavid A Haggstrom, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Indiana University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial focuses on understanding how the Survivorship Care Plan-Personal Health Record (SCP-PHR) can assist individuals who have had colon or rectal cancer. One group will use this tool to manage their care post-treatment, while the other group will receive standard written information. The trial aims to evaluate the tool's effectiveness and ease of use in managing long-term health. Suitable participants have recently completed treatment for Stage I, II, or III colon or rectal cancer within the past year and have regular internet access. As an unphased trial, this study provides a unique opportunity to contribute to research that could enhance long-term health management for future patients.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that the Survivorship Care Plan-Personal Health Record (SCP-PHR) is safe?

Research has shown that survivorship care plans (SCPs) are generally safe for patients. These plans assist cancer survivors in managing their health post-treatment by providing information and enhancing communication between doctors and patients. No specific safety issues have been reported for SCPs.

The Survivorship Care Plan-Personal Health Record (SCP-PHR) tool is a digital version of this plan, designed to simplify patient access to health information. Existing studies focus more on the effectiveness of these plans rather than safety concerns.

This trial is labeled "Not Applicable" for its phase, indicating it is not primarily testing safety but rather the effectiveness of the SCP-PHR. This generally suggests that the SCP-PHR is likely well-tolerated.12345

Why are researchers excited about this trial?

Researchers are excited about the Survivorship Care Plan-Personal Health Record (SCP-PHR) because it offers a novel way to support cancer survivors in managing their post-treatment health. Unlike traditional methods that provide written survivorship care information, SCP-PHR integrates a digital tool that empowers patients with easy access to their personalized health records. This approach not only enhances patient engagement but also facilitates a more proactive management of health, potentially leading to better long-term outcomes for cancer survivors.

What evidence suggests that the Survivorship Care Plan-Personal Health Record (SCP-PHR) is effective for cancer survivorship?

Research shows that a Survivorship Care Plan-Personal Health Record (SCP-PHR) can benefit cancer survivors. In this trial, participants in the intervention group will access the SCP-PHR tool, while the control group will receive written survivorship care information. A review of several studies has found that survivors with an SCP report better outcomes than those without one. Another study found that SCPs can improve health and healthcare for cancer survivors. However, some research did not find significant improvements in areas like satisfaction with treatment or depression. Overall, SCPs might help manage symptoms and provide better long-term care for cancer survivors.56789

Who Is on the Research Team?

DA

David Haggstrom, MD

Principal Investigator

Indiana University School of Medicine

Are You a Good Fit for This Trial?

This trial is for adults over 18 with stages I, II, or III colon or rectal cancer who finished initial treatment within the last year. They must speak English and have regular internet access. It's not for those with severe cognitive issues, in hospice care, a history of psychosis like schizophrenia, or cancer recurrence.

Inclusion Criteria

Patients must have regular (at least weekly) access to an internet connection, whether at home or elsewhere (family or friend)
I was treated for early-stage colon or rectal cancer in the last year.
English-speaking

Exclusion Criteria

I have severe difficulties with thinking, understanding, or remembering.
Patients currently in hospice care
My colorectal cancer has not come back after treatment.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Randomized Clinical Effectiveness Trial

Participants are involved in a randomized clinical effectiveness trial to assess the impact of the SCP-PHR on CRC surveillance, preventive care, and patient symptoms.

12 months

Mixed Methods Implementation Study

A qualitative process evaluation using semi-structured interviews to assess facilitators and barriers to implementation of the SCP-PHR among key stakeholders.

Concurrent with the effectiveness trial

Follow-up

Participants are monitored for safety and effectiveness after the trial, focusing on CRC surveillance, preventive care, and symptom management.

4-8 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Survivorship Care Plan-Personal Health Record (SCP-PHR)
Trial Overview The SPHERE trial is testing a Survivorship Care Plan-Personal Health Record (SCP-PHR) to see how effective it is and how well it can be implemented. Participants will be randomly assigned to receive this plan as part of an effectiveness study combined with a detailed analysis of its implementation.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Indiana University

Lead Sponsor

Trials
1,063
Recruited
1,182,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Published Research Related to This Trial

The review identified a lack of evidence regarding the utilization of survivorship care plans (SCPs) among Asian American cancer survivors, particularly focusing on breast cancer survivors of Southeast Asian descent.
Barriers to effective delivery of SCPs were linked to socioeconomic factors, highlighting the need for more research to improve care for this diverse population of survivors.
Survivorship Care Plan Preferences and Utilization Among Asian American Breast Cancer Survivors.Nolan, TS., Arthur, E., Nwodim, O., et al.[2022]
The analysis of 74 colorectal cancer survivorship care plans (SCPs) revealed that while over 80% included essential information about cancer diagnosis, treatment details, and health promotion, critical aspects like predisposing conditions and genetic counseling were less frequently documented.
Post-treatment surveillance recommendations were generally well-documented, with 100% adherence to guidelines for colonoscopy in Year 1, but significant variability was observed in other surveillance methods, indicating a need for more consistent recommendations across cancer centers.
Colorectal cancer survivorship care plans: Variations in documentation and posttreatment surveillance recommendations.Chodoff, A., Smith, KC., Shukla, A., et al.[2022]
A study comparing provider-initiated and patient-initiated web-based survivorship care plans (SCPs) found that both approaches faced significant barriers to implementation, with only 33% of providers enrolling and 61% of patients completing follow-up.
Despite the challenges, patients reported high levels of knowledge and confidence regarding their care, indicating that SCPs can be valuable tools for improving communication between patients and healthcare providers, regardless of who initiates the process.
Comparing Web-Based Provider-Initiated and Patient-Initiated Survivorship Care Planning for Cancer Patients: A Randomized Controlled Trial.Smith, KC., Tolbert, E., Hannum, SM., et al.[2020]

Citations

Survivorship Care Plans in Cancer: A Meta‐Analysis and ...Our meta‐analysis compares patient‐reported outcomes between SCP and no SCP (control) conditions for cancer survivors.
Systematic Review of the Impact of Cancer Survivorship ...This systematic review evaluates whether delivery of SCPs has a positive impact on health outcomes and health care delivery for cancer survivors.
Survivorship Care Plans: Initial Evidence of Impact on ...Results: Most (93%) of the sample had a family history of cancer; only 31% (n = 38) received some form of written care plan (SCP/treatment summary). Receipt of ...
A scoping review of the evidence on survivorship care ...This study found no significant improvements in patient-reported outcomes like treatment satisfaction, survivor concerns, depression, and impact ...
Division of Cancer Control & Population Sciences - Grant DetailsA survivorship care plan-personal health record (SCP-PHR) may also improve care for symptoms through the combination of longitudinal PHR- based symptom ...
Developing a survivorship care plan (SCP) delivery ...Survivorship care plans (SCPs) summarize patients' treatment and act as an education and communication tool between oncologists and primary care providers ( ...
Cancer Survivorship Care Plans - CDPH - CA.govThis toolkit was designed to help health care professionals and cancer centers to incorporate care plans into their survivorship programs.
National Standards for Cancer Survivorship CareCancer survivorship care standards represent recommendations for health systems to apply to the survivors they serve. These new standards can be utilized to ...
Digitizing Survivorship Care Plans Through the POST ...Background: Survivorship care plans (SCPs) are provided at the completion of cancer treatment to aid in the transition from active treatment ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security